Browsing Tag
Immunome
1 post
Why Immunome’s Phase 3 varegacestat data could reshape the desmoid tumor treatment market
Immunome is set to release Phase 3 varegacestat data that could redefine its oncology strategy and valuation. Read what this catalyst really means.